![Sierk Poetting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sierk Poetting
Geschäftsführer bei
BIONTECH SE
Vermögen: 50 Mio $ am 30.06.2026
Profil
Derzeit bekleidet Sierk Ptting die Position des Chief Operating & Financial Officer der BioNTech SE und ist Co-Geschäftsführer der JPT Peptide Technologies GmbH sowie Geschäftsführer der BioNTech Small Molecules GmbH (beides Tochtergesellschaften der BioNTech SE). In der Vergangenheit hatte Dr. Ptting die Position des VP & Chief Financial Officer-Sandoz Division bei der Novartis AG und des Chief Financial Officer & Vice President für Sandoz, Inc. (eine Tochtergesellschaft der Novartis AG) und Berater bei McKinsey GmbH & Co. KG. Er erhielt einen Abschluss von der University of Arizona und promovierte an der Ludwig-Maximilians-Universitt Mnchen.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIONTECH SE 0.22% | 12.05.2026 | 542’539 ( 0.22% ) | 50 Mio $ | 30.06.2026 |
Aktive Positionen von Sierk Poetting
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONTECH SE | Geschäftsführer | 01.09.2014 |
JPT Peptide Technologies GmbH
 JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Vorstandsvorsitzender | - |
BioNTech Europe GmbH
 BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Vorstandsvorsitzender | - |
IQM Finland Oy
 IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Vorsitzender | 03.03.2022 |
BioNTech Diagnostics GmbH
 BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Vorstandsvorsitzender | - |
BioNTech Delivery Technologies GmbH
 BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Sierk Poetting
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.08.2014 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Finanzdirektor/CFO | - |
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | - |
Ausbildung von Sierk Poetting
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPT Peptide Technologies GmbH
JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Health Technology |
BioNTech Diagnostics GmbH
BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Commercial Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
McKinsey GmbH & Co. KG
McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
BioNTech Europe GmbH
BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Health Technology |
IQM Finland Oy
IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Electronic Technology |
BioNTech Delivery Technologies GmbH
BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Commercial Services |
